Lung immune cell test for stage IV lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This research study looks at immune cells found in the fluid from a lung wash during bronchoscopy. It aims to see if these cells can help predict how well your cancer might respond to treatment or how the disease will progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You must have stage IV lung cancer (cancer that has spread) that is newly diagnosed or suspected.
- You must be scheduled to have a bronchoscopy (a test that looks inside your airways) with a lung wash as part of your routine care.
- You cannot have had treatment for a lung infection (like pneumonia or a fungal infection) in the last 4 weeks.
- You cannot have had an organ or bone marrow transplant, take immune-suppressing drugs, or have an autoimmune disease that requires such drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune cells inside lung tumors to better understand how they work. If you are having surgery for a thoracic tumor, your tissue could help researchers learn more.
This study looks for biological markers (special signs in your body) that could help doctors choose better immune-based treatments for non-small cell lung cancer. Researchers will study your tumor and blood to understand which patients might benefit most from immunotherapy.
This study looks at how immune cells in the lungs relate to the microbiome (the helpful microbes in the gut) in healthy adults. It may help scientists understand what affects lung health and immune balance.
This study collects blood and sputum (phlegm) samples from people with lung cancer before and during immunotherapy. The goal is to see if certain immune markers in these samples can predict how well the treatment works.
This Phase 1/2 study uses detailed “single-cell” testing (from lung samples) to better understand why lung inflammation happens after cancer radiation or immunotherapy. It aims to help choose the right treatment approach for people with radiation pneumonitis or immune checkpoint inhibitor pneumonitis.
This study examines how certain white blood cells behave in people with lung cancer or COPD. It aims to better understand the immune response, which could help develop new treatments.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.